Feb 24, 2026
University of Rochester received a grant from ARPA-H for $22 million dollars over five years to lead a research project to evaluate whether a drug previously used for HIV treatment can reduce a chronic immune response triggered by the body’s own DNA to protect health later in life.
Jan 29, 2024
Lifespan.io highlights a new study by Steve Horvath, Vera Gorbunova, and Alejandro Ocampo in which they used partial reprogramming to repair DNA damage in a mouse model of premature aging.
Dec 1, 2023
TheScientist interviews Vera Gorbunova about a fascinating molecular mechanism from naked-mole rats that has increased the median survival of genetically engineered mice.
Oct 9, 2023
VitaDAO is announcing the launch of Matrix Biosciences, a biotechnology company led by Vera Gorbunova. The launch comes with $300,000 in initial financing, with more funding to come in early 2024.
Oct 4, 2023
Forbes reports: Leading scientists including Vera Gorbunova sign the Dublin Declaration, a call for a concerted effort to improve both healthspan and lifespan.
Read more
Aug 23, 2023
Longevity gene from naked mole rats extends lifespan of mice. The successful transfer of a gene that produces HMW-HA paves the way for improving the health and lifespan of humans, too.
Read more
May 9, 2023
Vera Gorbunova on Long-Lived Species. Sirtuins apparently benefit some species more than others.
Read more
Feb 21, 2023
Longevity sirtuin clinical trial teases promising results. Gorbunova Aging Research Center team is encouraged by frailty results from SIRT6 activator trial.